Skip to main content
. 2026 Jul 3;17(7):780. doi: 10.3390/genes17070780
ASO Antisense Oligonucleotide
CMC Chemistry, Manufacturing, and Controls
CTiD Clinical-Trials-in-a-Dish
DMD Duchenne Muscular Dystrophy
EU European Union
hATTR Hereditary Transthyretin-Mediated Amyloidosis
IND Investigational New Drug
iPSC Induced Pluripotent Stem Cell
NAM New Approach Methodology
PK/PD Pharmacokinetics/Pharmacodynamics
siRNA Small Interfering RNA
SMA Spinal Muscular Atrophy
U.S. FDA United States Food and Drug Administration
WHO World Health Organization